Rapid in vivo zebrafish assays can help to resolve variant pathogenicity within weeks, providing organism-level evidence that informs treatment decisions, prevents unnecessary interventions, and strengthens precision medicine.
Abstract
Genomic screening increasingly reveals variants of uncertain significance, forcing clinicians to make high-stakes decisions as million-dollar drug and gene-replacement therapies emerge. Rapid in vivo zebrafish assays can help to resolve variant pathogenicity within weeks, providing organism-level evidence that informs treatment decisions, prevents unnecessary interventions, and strengthens precision medicine.
This issue of Cancer Cell, Hyeon et al. identify and map significantly mutated regions to protein domains and structural features, establishing a proteo-genomics framework for interpreting cancer mutations beyond genes and hotspots.
A Zebrafish-First Triage Strategy is proposed to screen potential therapeutic targets before mammalian validation and accelerate research and drug development in rare cancers.
Bruno Lopes-Bastos, Ewa Snaar-Jagalska· Trends in Cancer· 0 citations
Advances in precision genome editing and increased public support suggest that the field is ready for new clinical and regulatory pathways, including therapeutic germline gene editing.
Rare diseases affect hundreds of millions of individuals worldwide, primarily resulting from genetic factors, with many presenting during childhood. Advances in genome sequencing increasingly enable identification of the responsible gene in more patients; however, only a limited selection of therapies exists to correct...
Sarfaraz K. Niazi· Communications Medicine· 0 citations
Pooling functionally distinct variant classes within a single gene can mislead treatment inference. Using PTPN11 and growth hormone therapy in Noonan spectrum disorders, this Perspective shows that functionally divergent variants, including gain- of-function, loss- of-function, and dominant-negative classes, may coexis...
P. Heneberg· Clinical pharmacology and th...· 0 citations
low-lying and novel mutations. We recommend incorporating WGS into the national TB diagnostic algorithms for monitoring treatment failures, research, and control programmes to improve outcomes and work toward ending TB. We also recommend strengthening laboratory and administrative systems to prevent diagnostic and admi...
B. Makamure, J. Phelan, T. Bandason et al.· IJTLD open· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
